Hidden Dangers: What Opioid Management Programs Are Missing

Dr. Kendra Karagozian will discuss an innovative approach to address adverse drug events and the importance of personalized medication therapy. Learning objectives include:

• Recognize traditional opioid management programs and measures
• Review data that demonstrates the need to address drug-drug interactions with opioids and how they could lead to unintended overdose and adverse outcomes
• Identify a comprehensive approach to evaluate medication regimens that include opioids